MissionIR Articles
-
MissionIRNewsBreaks – MoonLake Immunotherapeutics’ (NASDAQ: MLTX) Shares See Significant Increase Based on Success of IL-17 Nanobody Phase 2 Trial
MoonLake (NASDAQ: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, has announced positive top-line results from its global phase 2 MIRA trial. The trial (“M1095-HS-201”) evaluated the efficacy and safety of the Nanobody(R) Sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (“HS”). MoonLake’s shares closed nearly $20.00 up on the day…
-
MissionIRNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) Now Included in Russell Microcap(R) Index
NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, is joining the Russell Microcap(R) Index, effective today. The company announced that it will be included following the conclusion of the 2023 Russell indexes annual reconstitution. According to the announcement, Russell Microcap Index membership is in effective for one year and consists of automatic inclusion in the appropriate…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Shines Spotlight on Autonomous Security Technologies in New Blog Series
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that it published a series of blogs targeting both public and private sectors. The content highlights numerous recommendations that will assist law enforcement and security professionals in adopting autonomous security technologies. The announcement reads, Knightscope’s advice was…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Secures Contract Renewal with K-FLEX de México
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process as well as providing its Fr8App platform for B2B cross-border shipping in the USMCA region. The company announced that it has been recognized for outstanding service by K-FLEX de México and has secured a renewal of…
-
MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Working to Deliver Novel Treatment for Chronic Pain Sufferers
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, recently announced a new research and development agreement to create a time-release ketamine implant to treat fibromyalgia and other chronic pain conditions. Silo intends to leverage its existing partnerships with academic research institutions to help move the novel…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) to be Showcased at Upcoming Tesla Event
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced that its Robot Roadshow will be landing in San Luis Obispo, California, at Tesla Takeover 2023. The announcement reads, “Tesla Takeover is July 29-30, 2023, at the Fields at Madonna Inn located at 100 Madonna Road in…
-
MissionIRNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Reshaping the Concept of Cybersecurity
CISO Global Inc. (NASDAQ: CISO), an industry leading cybersecurity and compliance provider, understands that, to win the cyber war, a combination of talented experts and the latest technology must be deployed effectively. This is the culture and value proposition that CISO Global brings to its customers. The company offers a combination of security and compliance…
-
MissionIRNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Announces Third Deadline Date Extension to Complete Initial Business Combination
Fintech Ecosystem Development Corp. (NASDAQ: FEXD) today announced that its board of directors has decided to extend the date by which the company must consummate an initial business combination (the “deadline date”) from June 21, 2023, for an additional month, to July 21, 2023. The company’s sponsor, Revofast LLC, deposited $110,000 into the company’s trust…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) 755-201-EB Trial Demonstrates Clinically Important Results
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced safety and efficacy results from its phase 2 clinical trial. The purpose of the trial, called “755-201-EB,” was to evaluate the safety of INM-755 CBN cream, which consists of the control cream plus…
-
MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Secures US Patent for SPU-21 Treatment for Autoimmune Disease
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that the U.S. Patent and Trademark Office (“USPTO”) has issued U.S. Patent 16/825,371 titled “Peptide-Targeted Liposomal Delivery for Treatment, Diagnosis and Imaging of Diseases and Disorders.” According to the announcement, the new patent claims cover the…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Secures New Orders for K1 Retrofit, Call Boxes
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, has announced its receipt of a purchase order from San Francisco Bay Area Rapid Transit (“BART”) to expand its emergency communications system with three K1 Call Boxes. In addition, a university in the northeast is updating two of its…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Moratorium on New Financings, Sufficient Capital for at Least 12 Months
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced an investor financing moratorium for the balance of 2023 and that it has sufficient capital on hand for at least the next 12 months. In addition, the company confirmed that remaining investor option expires on June 30, 2023, and that its assets are…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands IP Portfolio with Four New Patents
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of four newly granted patents. The company secured two new Canadian patents, its 18th in its patent family No. 1: Food and Beverage Compositions Infused with Lipophilic Active Agents and Methods of Use Thereof, and No. 8 in its:…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Working on Broad Commercialization of AI-Powered PERSONA Vehicle Technology
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the integration of AI-powered PERSONA vehicle technology into its overall commercial and consumer vehicle lineups. Originally developed for the Mullen FIVE, PERSONA is an advanced interactive AI camera/sensor and video monitoring system that utilizes facial recognition technology to unlock/lock vehicles and completely personalize…
-
MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Announces 2023 PEA Results on Los Azules Copper Project
McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) today provided results of the updated Preliminary Economic Assessment (the “2023 PEA”) on the Los Azules Copper Project in San Juan Argentina (the “project”). The project is 100% owned by McEwen Copper Inc., which is 52% owned by McEwen Mining. According to the announcement, the PEA includes an…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announces Upcoming Robot Roadshow in West Texas
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is releasing the next landing destination for its popular Robot Roadshow. The company announced that the engaging, in-person experience is slated to be at the Outlet Shoppes at El Paso on June 20–21, 2023; the roadshow will be…
-
MissionIRNewsBreaks – Genprex Inc.’s (NASDAQ: GNPX) Flagship Candidate Could Potentially Reshape NSCLC Landscape
Genprex (NASDAQ: GNPX) is conducting its Phase 1/2 Acclaim-1 clinical trial evaluating the safety and efficacy of combining REQORSA(R), the company’s innovative drug candidate, in combination with Tagrisso(R) in patients with advanced EGFR mutant non-small cell lung cancer (“NSCLC”) who have experienced disease progression after previous treatments. “REQORSA Immunogene Therapy represents a potentially groundbreaking experimental…
-
MissionIRNewsBreaks – Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Committed to Supporting Fintech, Digital Money Processes in Underserved Markets
Fintech Ecosystem Development Corp. (NASDAQ: FEXD) continues to move forward with plans to offer a diverse portfolio of fintech-related products and services for consumers and businesses throughout the global financial ecosystem. “Digital money is replacing physical cash, with consumers able to buy products and services anywhere in the world and make payments across borders. FEXD…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on Promising Results from Diabetes Animal Study
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is releasing additional findings from its DIAB-A22-1 study, a diabetes animal study designed to evaluate the company’s proprietary DehydraTECH-CBD. DehydraTECH is a patented drug-delivery formulation and processing platform technology developed by Lexaria. The company noted that in addition to the three positive outcomes reported earlier…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Corrects Shareholder Letter to Reflect $0.38 Per Share
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has released a letter to its shareholders designed to address the decrease in the company’s share price. The letter noted that earlier this week, the company’s common stock closed at $0.32 per share, down 90% since the end of March. The company currently trades at…
Search Articles
Latest Articles
- Beeline Holdings, Inc. (NASDAQ: BLNE) Clears Debt and Boosts Revenue, On Track to Becoming Cash Flow Positive by Early 2026
- MissionIRNewsBreaks – Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) Highlighted in Cantor Report for Growth Potential and Sector Strength
- MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) to Begin Trading as Solmate (NASDAQ: SLMT) on Oct. 3
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Builds Domestic Supply Chain Using RapidSX Technology
- Forward Industries Inc. (NASDAQ: FORD) Is ‘One to Watch’